The disposition of SFB-G can also be affected by the activity of UGTs, although it is unlikely that UGT1A9 metabolism is a significant contributor to the variability in SFB-G disposition observed in NASH. Here, UGT1A9 is linked to metabolic dysfunction-associated steatohepatitis.